MAPT and Alzheimer disease: GSK-3β has been extensively studied in the context of AD, and it has been implicated in a variety of cellular processes that are disturbed in AD, including Aβ generation [79], tau phosphorylation [80], synaptic plasticity [81], and inflammation [82].